This website uses cookies to make the content more user-friendly and effective. By using this website, you agree to the use of cookies. You can find additonal information about the use of cookies and the possibility of objecting to the use of cookies here.

31 March - 2 April 2020 // Nuremberg, Germany

Posting print layout

What information should be shown in the print layout?

Create print layout
Exhibitors & Products MedtecLIVE 2019
Zoom product LOGO_Extractables and Leachables

Extractables and Leachables

LOGO_Extractables and Leachables

Extractables and Leachables

Request information Request information

Contact us

Please enter your personal information and desired appointment. You can also leave us a message.

Your personal information

Your message for us

Desired appointment during the exhibition

* Compulsory fields you must fill in.

Information on data protection can be found here.

Send
Your message has been sent.

You do not have a registration yet? Register now and use all advantages of the Exhibitors and Products Database, the supporting programme and the TicketShop.

An error has occurred.

Extractables and Leachables are organic or inorganic impurities originating from primary packaging material (plugs, blisters, vials, etc.) or production tools.  Pharmaceutical companies and medical device manufacturers must analyze extractables and leachables (E&L studies) for new pharmaceutical products. This also includes the toxicological assessment of extractables.

SYNLAB Analytics & Services Germany GmbH divides E & L studies into 4 essential production steps:

1. Extractables Study:
Extractables are chemical compounds extracted from primary packaging materials under extreme conditions (high temperatures, different solvents, pH and periods of stress).
Then,  the extractables are analyzed using  highly sensitive analytical methods, such as LC Q-ToF MS, LC-MS / MS, GC-MS, Headspace-GC-MS, and SPME-GC-MS.
In close consultation with our customers, Analytical Services defines the AET value (analytical estimated threshold).

2. Simulations Study:
The simulation study is an intermediate step to more reliably represent extractables as probable leachables in placebo and drug products stored under extreme conditions. The analysis of extractables from the simulation study is performed similarly to the extractables study using highly sensitive analytical methods.

3. Toxikological Assesment:
All extracts obtained from the extractable study are evaluated from a toxicology perspective. A detailed extractables report estimating the toxicological and genotoxicological characteristics of the extractables is then forwarded to our client. Only the extractables above the AET value are considered for such a toxicological assessment.

4. Leachables Study:
Leachables are chemical compounds that are released from packaging materials, coatings and locking mechanisms under normal environmental conditions. Please note that not all leachables in the previous extractables study were necessarily found, because some pharmaceutical formulations can cause a reorganization of known, extractable chemical compounds. Therefore, the correlation of extractables results with potential leachables requires experience and a special circumspection .
Synlab Analytics & Services Germany GmbH performs all E & L testing in our in-house GMP analysis laboratories according to the latest official guidelines. Our state-of-the-art equipment enables the detection of extractables & leachables at ultra trace Levels.
 

Extractables & Leachables Summary:

  • E&L  studies are divided into 4 steps: the extractables study, the simulation study, the toxicological evaluation and the leachables study
  • extractables & leachables studies are carried out in our GMP laboratory according to the most recent guidelines
  • stress and compatibility studies of packaging materials are included
     

The leachables and extractables studies are realized according to the following guidelines:

  • ISO 10993: Biologial evaluation of medical devices
  • FDA Guidances for Industry on inhalation drug products
  • EMA/Health Canada guideline on the pharmaceutical quality of inhalation and nasal products, October 2006
  • Recommendations of the Product Quality Research Institute (PQRI) Leachables and Extractables Working Group “Safety Thresholds and Best Practices for Extractables and Leachables in
  • Orally Inhaled and Nasal Drug Products (OINDP)”, September 2006
  • Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Products (PODP), Paskiet, D. et al., PDA J Pharm Sci and Tech 2013, 67
  • SFDA: Draft Technical Guideline for Compatibility Studies between Chemical Drug Injections and Plastic Packaging Materials
  • EMA Guideline on Plastic Immediate Packaging Materials (CPMP/QWP/4359/03)
     

More information

This embedded video is provided by YouTube. When the video plays, usage data is transmitted to YouTube. If you agree, click "Start Video" to play the video.

Product video

 Play video 

You decided to attend the MedtecLIVE? Get your tickets at the TicketShop



top

The selected entry has been placed in your favourites!

If you register you can save your favourites permanently and access all entries even when underway – via laptop or tablet.

You can register an account here to save your settings in the Exhibitors and Products Database and as well as in the Supporting Programme.The registration is not for the TicketShop and ExhibitorShop.

Register now

Your advantages at a glance:

  • Advantage Save your favourites permanently. Use the instant access – mobile too, anytime and anywhere – incl. memo function.
  • Advantage The optional newsletter gives you regular up-to-date information about new exhibitors and products – matched to your interests.
  • Advantage Call up your favourites mobile too! Simply log in and access them at anytime.